Literature DB >> 20300842

Vulnerable sites and changes in mucin in the rat small intestine after non-steroidal anti-inflammatory drugs administration.

Tomohisa Iwai1, Takafumi Ichikawa, Mitsuhiro Kida, Yukinobu Goso, Yoichi Saegusa, Isao Okayasu, Katsunori Saigenji, Kazuhiko Ishihara.   

Abstract

BACKGROUND AND AIMS: The location of mucosal damage and changes in mucin content in the rat small intestine following administration of non-steroidal anti-inflammatory drugs (NSAIDs) have not been well elucidated.
METHODS: After subcutaneous administration of loxoprofen sodium (10-40 mg/kg), the small intestinal mucosa of male Wistar rats was evaluated macroscopically, histologically, and immunohistochemically by measuring the total mucin content and immunoreactivity for anti-mucin monoclonal antibody, HCM31, 1, 3, 7, and 14 days later. Changes in the number of enterobacteria invading the mucosa around the lesions were also determined.
RESULTS: Loxoprofen sodium induced erosions and ulcers along the mesenteric margin of the distal jejunum. Early (≤6 h) mucosal lesions were small and round, located between the branches of the mesenteric arteries. In the jejunum, there was a transient increase in the total mucin content, and HCM31-positive mucin in the mucosa around the ulcers increased significantly on days 3 and 7, but in the ileum there were no marked changes and few ulcers. Bacterial translocation following loxoprofen sodium administration significantly increased, according to the site of the intestinal lesions.
CONCLUSIONS: Vascularly compromised sites along the jejunal mesenteric margin are vulnerable to NSAIDs-induced damage and show increased numbers of enterobacteria in the NSAIDs-treated mucosa. Increased sialomucin content in the mucus around the lesions may play an important role in the healing of NSAIDs-induced intestinal lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300842     DOI: 10.1007/s10620-010-1185-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin.

Authors:  Adrian Allen; Gunnar Flemström
Journal:  Am J Physiol Cell Physiol       Date:  2005-01       Impact factor: 4.249

2.  Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.

Authors:  H Mizoguchi; Y Ogawa; K Kanatsu; A Tanaka; S Kato; K Takeuchi
Journal:  J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 4.029

3.  Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.

Authors:  Ryo Hatazawa; Ryoko Ohno; Mayu Tanigami; Akiko Tanaka; Koji Takeuchi
Journal:  J Pharmacol Exp Ther       Date:  2006-05-12       Impact factor: 4.030

4.  Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.

Authors:  B K Reuter; N M Davies; J L Wallace
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

5.  Correlation of gastric mucosal damage with sialic acid profile in rats: effect of hydrochloric acid, pepsin and hypertonic saline.

Authors:  Sadiq Yusuf; Andrew J Nok; Danladi A Ameh; Alexander B Adelaiye; Emmanuel O Balogun
Journal:  Cell Biochem Funct       Date:  2005 Sep-Oct       Impact factor: 3.685

6.  Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.

Authors:  Yasumasa Niwa; Masanao Nakamura; Naoki Ohmiya; Osamu Maeda; Takafumi Ando; Akihiro Itoh; Yoshiki Hirooka; Hidemi Goto
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

7.  Effects of indomethacin on the rat small intestinal mucosa: immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies.

Authors:  Tomohisa Iwai; Takafumi Ichikawa; Yukinobu Goso; Tomoaki Ikezawa; Yoichi Saegusa; Isao Okayasu; Katsunori Saigenji; Kazuhiko Ishihara
Journal:  J Gastroenterol       Date:  2009-03-13       Impact factor: 7.527

8.  Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.

Authors:  Takafumi Ichikawa; Hiroyoshi Ota; Atsushi Sugiyama; Fukuto Maruta; Tomoaki Ikezawa; Kyoko Hotta; Kazuhiko Ishihara
Journal:  J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 4.029

9.  Microcirculatory changes in experimental mesenteric longitudinal ulcers of the small intestine in rats.

Authors:  Kayoko Shimizu; Hideki Koga; Mitsuo Iida; Ken Haruma
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

10.  Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats.

Authors:  Y Azuumi; S Ohara; K Ishihara; H Okabe; K Hotta
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

View more
  5 in total

1.  FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.

Authors:  Hyder Said; Yasutada Akiba; Kazuyuki Narimatsu; Koji Maruta; Ayaka Kuri; Ken-Ichi Iwamoto; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2017-05-18       Impact factor: 3.199

2.  FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.

Authors:  Yasutada Akiba; Koji Maruta; Kazuyuki Narimatsu; Hyder Said; Izumi Kaji; Ayaka Kuri; Ken-Ichi Iwamoto; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

3.  Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats.

Authors:  Atsuki Yamamoto; Tomokazu Itoh; Reishi Nasu; Ryuichi Nishida
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

4.  Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats.

Authors:  Takuya Inoue; Masaaki Higashiyama; Izumi Kaji; Sergiy Rudenkyy; Kazuhide Higuchi; Paul H Guth; Eli Engel; Jonathan D Kaunitz; Yasutada Akiba
Journal:  Dig Dis Sci       Date:  2013-12-31       Impact factor: 3.199

5.  Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model.

Authors:  Satoshi Kurata; Takako Nakashima; Takako Osaki; Naoya Uematsu; Masafumi Shibamori; Kazushi Sakurai; Shigeru Kamiya
Journal:  J Clin Biochem Nutr       Date:  2014-10-04       Impact factor: 3.114

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.